CLASS II Device recall · Reported 25 Dec 2019 · FDA Enforcement Report

Roche Homocysteine-In vitro test recalled

Roche Diagnostics Operations is recalling Roche Homocysteine-In vitro test for the quantitative determination of total, distributed nationwide in the US. The recall was initiated on 4 Oct 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Number: 422313 Exp Date: 07/31/2020
Quantity recalled82 units (US)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0679-2020
FDA event ID
84018
Recalling firm
Roche Diagnostics Operations, Indianapolis, IN
Classification
Class II
Status
Terminated
Recall initiated
4 Oct 2019
FDA classified
13 Dec 2019
Reported
25 Dec 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

4 Oct 2019Recall initiated by company
13 Dec 2019Classified by FDA+70 days
25 Dec 2019Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Homocysteine Reagent, Calibration Failures and Quality Control Recovery Issues on cobas c 701 and 702 modules

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Roche Homocysteine-In vitro test for the quantitative determination of total L-homocysteine in human serum and plasma on Roche/Hitachi cobas c systems Catalog Number: 06542921190 - - Product Usage: The assay can assist in the diagnosis of patients suspected of having hyperhomocysteinemia or homocystinuria.

Where it was distributed

US Nationwide distribution in the states of NJ, HI, IA.

Nationwide HawaiiIowaNew Jersey

Questions about this recall

Why was it recalled?

Homocysteine Reagent, Calibration Failures and Quality Control Recovery Issues on cobas c 701 and 702 modules

Which lots are affected?

Lot Number: 422313 Exp Date: 07/31/2020

Where was it sold?

US Nationwide distribution in the states of NJ, HI, IA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Roche Diagnostics Operations

All 127

Other Test Kits & Diagnostics recalls

All 2,663